The Gastroesophageal Reflux Disease (GERD) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Gastroesophageal Reflux Disease (GERD) Market?
The global market size of Gastroesophageal Reflux Disease (GERD) has seen slight growth recently. It is forecasted to rise from $5.25 billion in 2024 to $5.35 billion in 2025, with a compound annual growth rate (CAGR) of 2.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Gastroesophageal Reflux Disease (GERD) Industry?
By 2029, the global gastroesophageal reflux disease (GERD) market is projected to reach a value of $5.94 billion, growing at a compound annual growth rate (CAGR) of 2.7%.
Download Your Free Sample of the 2025 Gastroesophageal Reflux Disease (GERD) Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Gastroesophageal Reflux Disease (GERD) Market?
The key drivers in the gastroesophageal reflux disease (gerd) market are:
• Aging population contributing to an increase in GERD cases
• Rising healthcare expenditure worldwide
• Advancements in the field of targeted therapies for GERD
• Growing demand for medical equipment and devices for GERD diagnosis and treatment
Global Market Segmentation: Identifying Major Gastroesophageal Reflux Disease (GERD) Industry Segments
The gastroesophageal reflux disease (GERD) market covered in this report is segmented –
1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF)
2) By Procedure: Invasive, Minimally Invasive
3) By End-Users: Hospital, Homecare, Specialty Clinics
Pre-order the 2025 Gastroesophageal Reflux Disease (GERD) Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Gastroesophageal Reflux Disease (GERD) Market?
The key trends in the gastroesophageal reflux disease (gerd) market are:
• There is a trend of advancements in diagnostic practices for GERD.
• Surgical techniques in treating GERD are seeing continuous improvements.
• The development of targeted therapies is an emerging trend within the market.
• The adoption of telehealth services is increasingly shaping the GERD market.
Who Are the Top Competitors & Leading Players in the Gastroesophageal Reflux Disease (GERD) Market?
Major companies in the gastroesophageal reflux disease (gerd) market are:
• GlaxoSmithKline PLC
• SRS Life Sciences
• Johnson & Johnson Services Inc.
• Takeda Pharmaceutical Company Limited
• AstraZeneca PLC
• Reckitt Benckiser Group PLC
• Eisai Co. Ltd.
• Pfizer Inc.
• Medtronic PLC
• Teva Pharmaceuticals
• HK inno.N Corporation
• Sebela Pharmaceuticals
• Mylan N.V.
• Bausch Health Companies Inc.
• Johnson & Johnson MedTech
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company PLC
• Dr. Reddy's Laboratories Ltd.
• Aurobindo Pharma Limited
• Cipla Limited
• Ferring B.V.
• Amneal Pharmaceuticals LLC
• Zydus Lifesciences Ltd.
• Lupin Limited
• Torrent Pharmaceuticals Ltd.
• Salix Pharmaceuticals Inc.
• Almirall S.A.
• HK inno.N Corporation
• SRS Life Sciences Pte. Ltd.
Regional Dominance: Which Area Leads the Global Gastroesophageal Reflux Disease (GERD) Market?
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2024
